Online citations, reference lists, and bibliographies.
Please confirm you are human
(Sign Up for free to never see this)
← Back to Search

Familial Risk In Patients With Carcinoma Of Unknown Primary.

N. Samadder, K. Smith, H. Hanson, R. Pimentel, J. Wong, K. Boucher, W. Akerley, G. Gilcrease, C. Ulrich, R. Burt, K. Curtin
Published 2016 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
IMPORTANCE Carcinoma of unknown primary (CUP) accounts for 3% to 5% of all cancers and is associated with poor prognosis. Familial clustering of different cancer sites with CUP is unknown and may provide information regarding etiology, as well as elevated cancer risks in relatives. OBJECTIVE To quantify the risk of cancer by site in first- and second-degree relatives and first cousins of individuals with CUP. DESIGN, SETTING, AND PARTICIPANTS Nested case-control study of patients who received a diagnosis of CUP between 1980 and 2010 identified from the Utah Cancer Registry. Population controls with no CUP diagnosis were sex and age matched 10:1 to patients with CUP. Data about relatives were drawn from the Utah Population Database. MAIN OUTCOMES AND MEASURES Familial aggregation of cancer risk in relatives of cases compared with controls using Cox regression analysis. RESULTS For the 4160 index patients (median [interquartile range] age, 72 [62-81] years; 47.6% male) who had received a diagnosis of CUP, first-degree relatives were at an elevated risk of CUP themselves (hazard ratio [HR], 1.35 [95% CI, 1.07-1.70]), as well as lung (HR, 1.37 [95% CI, 1.22-1.54]), pancreatic (HR, 1.28 [95% CI, 1.06-1.54]), myeloma (HR, 1.28 [95% CI, 1.01-1.62]), and non-Hodgkin lymphoma (HR, 1.16 [95% CI, >1.00-1.35]) cancers compared with controls without CUP. When the analysis was restricted to relatives of cancer-free controls, additional increased risks for colon (HR, 1.19 [95% CI, 1.06-1.33]) and bladder (HR, 1.18 [95% CI, >1.00-1.38]) cancers were observed. Second-degree relatives of patients with CUP were at a slight increased risk of lung (HR, 1.14 [95% CI, 1.03-1.26]), pancreatic (HR, 1.17 [95% CI, 1.01-1.37]), breast (HR, 1.09 [95% CI, 1.02-1.16]), melanoma (HR, 1.09 [95% CI, >1.00-1.19]), and ovarian (HR, 1.19 [95% CI, 1.02-1.39]) cancers. CONCLUSIONS AND RELEVANCE Relatives of patients with CUP are at increased risk of CUP and several other malignant neoplasms, including lung, pancreatic, and colon cancer. The present data may suggest sites of origin for CUP and provide cancer risk information for relatives of patients with CUP that can lead to effective intervention. Relatives of patients with CUP should be aware of the elevated risks for lung, pancreatic, and colon cancer and encouraged to modify risk factors and adhere to site-specific population cancer screening.
This paper references
10.1038/bjc.2013.386
Cancer of unknown primary: a population-based analysis of temporal change and socioeconomic disparities
D. Urban (2013)
10.1200/JCO.2010.31.5614
Familial risks in cancer of unknown primary: tracking the primary sites.
K. Hemminki (2011)
10.7861/CLINMEDICINE.8-4-451
Cancer of unknown primary site.
C. Gallagher (2008)
10.1093/JNCI/65.5.1083
Cancer risk factors: an analysis of Utah Mormons and non-Mormons.
D. West (1980)
10.1200/JCO.2010.30.5664
Familial mortality and familial incidence in cancer.
K. Hemminki (2011)
10.1002/ijc.21236
Lobular breast cancer: Excess familiality observed in the Utah Population Database
K. Allen-Brady (2005)
10.1111/J.0006-341X.2000.00645.X
A note on robust variance estimation for cluster-correlated data.
R. Williams (2000)
10.1002/ijc.24795
The Swedish Family‐Cancer Database 2009: prospects for histology‐specific and immigrant studies
K. Hemminki (2010)
10.1111/j.1469-1809.1989.tb01803.x
Inbreeding in the Utah Mormons: an evaluation of estimates based on pedigrees, isonymy, and migration matrices
L. Jorde (1989)
10.1016/J.EJCA.2007.06.023
Switching benchmarks in cancer of unknown primary: from autopsy to microarray.
G. Pentheroudakis (2007)
10.1093/annonc/mdn527
Age of onset in familial cancer.
A. Brandt (2008)
10.1111/apt.13086
Familial colorectal cancer risk by subsite of primary cancer: a population‐based study in Utah
N. Samadder (2015)
10.1002/ijc.28266
Familial risk of childhood cancer and tumors in the li‐fraumeni spectrum in the utah population database: Implications for genetic evaluation in pediatric practice
K. Curtin (2013)
10.4135/9780857020116.n23
[Cohort study].
M. Okano (2014)
10.1038/gim.2011.2
A comprehensive survey of cancer risks in extended families
Craig C Teerlink (2012)
10.1016/j.cgh.2015.06.040
Increased Risk of Colorectal Cancer Among Family Members of All Ages, Regardless of Age of Index Case at Diagnosis.
N. Samadder (2015)
10.1016/j.cgh.2015.08.033
Risk of Incident Colorectal Cancer and Death After Colonoscopy: A Population-based Study in Utah.
N. Samadder (2016)
10.1002/PROS.20248
Population‐based risk assessment for other cancers in relatives of hereditary prostate cancer (HPC) cases
L. C. Albright (2005)
10.1371/journal.pmed.0010065
Cancer as a Complex Phenotype: Pattern of Cancer Distribution within and beyond the Nuclear Family
Laufey T Amundadottir (2004)
10.1053/j.gastro.2008.02.002
Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology.
B. Levin (2008)
Familiality of cancer in Utah.
L. Cannon-Albright (1994)
cancer ( HPC ) cases
JL Bermejo (2005)
American College of Gastroenterology guidelines for colorectal cancer screening 2009 [ corrected ]
B Levin (2009)
10.1016/j.cgh.2010.05.012
A population-based description of familial clustering of pancreatic cancer.
B. Shirts (2010)
10.1002/ijc.24178
Sex‐specific familial risks of urinary bladder cancer and associated neoplasms in Sweden
J. Bermejo (2009)
10.1002/cncr.20989
A cohort study of cancer risk in relation to family histories of cancer in the Utah population database
R. Kerber (2005)
10.1093/JNCI/86.21.1600
Systematic population-based assessment of cancer risk in first-degree relatives of cancer probands.
D. Goldgar (1994)
10.2307/2529310
The measurement of observer agreement for categorical data.
J. Landis (1977)
10.1038/ajg.2009.104
American College of Gastroenterology Guidelines for Colorectal Cancer Screening 2008
D. Rex (2009)
10.2307/2529786
An application of hierarchical kappa-type statistics in the assessment of majority agreement among multiple observers.
J. Landis (1977)
10.1136/bmj.e8076
Familial risk of early and late onset cancer: nationwide prospective cohort study
E. Kharazmi (2012)
10.1093/OXFORDJOURNALS.AJE.A010297
Bias associated with study protocols in epidemiologic studies of disease familial aggregation.
Y. Bai (2000)
American College of Gastroenterology. American College of Gastroenterology guidelines for colorectal cancer screening 2009 [corrected
DK Rex (2009)



This paper is referenced by
10.15406/jcpcr.2017.07.00242
The Molecular Connections between Lung and Pancreatic Cancer Metastases: are we not seeing the Forest for the Trees?
Angelo Wilson (2017)
10.1002/ijc.32316
Comparative genetic profiling aids diagnosis and clinical decision making in challenging cases of CUP syndrome
T. Bochtler (2019)
10.1007/s10147-019-01491-1
Familial cancer of unknown primary
E. Rassy (2019)
10.3889/oamjms.2017.222
Primary Solitary Melanoma of the Lymphatic Nodes Or a Single Metastasis of Unknown Melanoma: Do We Need a New Staging System?
G. Tchernev (2017)
10.1016/j.bulcan.2016.10.022
[Carcinoma of unknown primary site: From necropsy to epigenetic analysis].
Nicolas Penel (2017)
10.1001/jamaoncol.2015.4653
Familial Carcinoma of Unknown Primary.
H. Lynch (2016)
10.1007/s00761-017-0269-8
Karzinom bei unbekanntem Primärtumor
M. Ståhl (2017)
10.1007/s00535-019-01597-3
Familial pancreatic cancer risk: a population-based study in Utah
Divyanshoo R. Kohli (2019)
10.1053/j.semdp.2017.11.013
Diagnosis and management of metastatic neoplasms with unknown primary.
T. Bochtler (2018)
10.1016/j.clbc.2018.04.009
Inducing or Preventing Subsequent Malignancies for Breast Cancer Survivors? Double‐edged Sword of Estrogen Receptor and Progesterone Receptor
Zhe-yu Hu (2018)
10.1016/J.BULCAN.2016.10.022
Cancers de primitif inconnu : de l’autopsie à l’analyse épigénétique
N. Penel (2017)
10.1101/19003681
Redefining the Bladder Cancer Phenotype using Patterns of Familial Risk
H. Hanson (2019)
10.3389/fonc.2019.01546
“Metastatic Cancer of Unknown Primary” or “Primary Metastatic Cancer”?
Stefan Kolling (2019)
10.1053/j.semdp.2020.12.001
The role of molecular profiling in the diagnosis and management of metastatic undifferentiated cancer of unknown primary✰: Molecular profiling of metastatic cancer of unknown primary.
J. K. Dermawan (2020)
Semantic Scholar Logo Some data provided by SemanticScholar